Drug Patents Expiring in 2018

The list below is comprised of prescription medications slated for drug patent expirations in 2018. As these dates approach, Carlisle Medical will seek opportunities to transition claimants to the generic medication versions as they become available. Please note, these are anticipated generic launch dates and are subject to change.

Treximet
Generic Name: Sumatriptan/Naproxen
Used to treat migraines with or without aura.
Patent Expiration Date: February 2018

Sensipar
Generic Name: Cinacalcet
Used to treat patients with chronic kidney disease who are on dialysis. It is also used to treat high levels of calcium in the blood of patients with certain parathyroid gland problems.
Patent Expiration Date: March 2018

Spiriva
Generic Name: Tiotropium
Used for maintenance treatment of chronic obstructive pulmonary disease (COPD) which includes chronic bronchitis and emphysema.
Patent Expiration Date: July 2018

Tekturna
Generic Name: Aliskiren/hctz
Used to treat high blood pressure.
Patent Expiration Date: July 2018

Cialis
Generic Name: Tadalafil
Used to treat erection problems in men. It is also used for enlargement of the prostate gland in men, a condition called benign prostatic hyperplasia or BPH.
Patent Expiration Date: September 2018

Symbicort
Generic Name: Budesonide/formoterol
Used to treat asthma. It is also used to treat chronic obstructive pulmonary disease, including chronic bronchitis or emphysema.
Patent Expiration Date: September 2018

Levitra
Generic Name: Vardenafil
Used for the treatment of erectile dysfunction (ED) in men.
Patent Expiration Date: October 2018

Staxyn
Generic Name: Vardenafil
Used for the treatment of erectile dysfunction (ED) in men.
Patent Expiration Date: October 2018

Vesicare
Generic Name: Solifenacin
Used to treat overactive bladder.
Patent Expiration Date: October 2018

Fortesta
Generic Name: Testosterone
Used in males to treat low testosterone levels.
Patent Expiration Date: November 2018

Lyrica
Generic Name: Pregabalin
Used to treat nerve pain from diabetes, shingles, spinal cord injury, and fibromyalgia. It is also used to control seizures in epilepsy.
Patent Expiration Date: December 2018

Rapaflo
Generic Name: Silodosin
Used to treat enlargement of the prostate gland in men, a condition called benign prostatic hyperplasia or BPH.
Patent Expiration Date: December 2018

Please contact us at 800-553-1783 or at pharmacy@carlislemedical.com if you have any questions on this announcement or if our pharmacy staff may assist you in any way.